Lynwood Capital Management Inc. - Q4 2022 holdings

$83.1 Thousand is the total value of Lynwood Capital Management Inc.'s 131 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 255.6% .

 Value Shares↓ Weighting
BCTX BuyBRIACELL THERAPEUTICS CORP$6,687
-99.9%
1,530,000
+27.7%
8.04%
+9.4%
PYPL NewPAYPAL HLDGS INC$2,84940,000
+100.0%
3.43%
ATCO BuyATLAS CORPshares$2,685
-99.7%
175,000
+140.4%
3.23%
+192.3%
XFOR NewX4 PHARMACEUTICALS INC$2,1412,155,100
+100.0%
2.58%
STOR BuySTORE CAP CORP$2,084
-99.9%
65,000
+18.2%
2.51%
+33.3%
BuySPORTSMAP TECH ACQUISITIN CO$2,043
-99.9%
200,108
+25.0%
2.46%
+40.2%
BuyLEGATO MERGER CORP II$1,738
-99.9%
170,002
+1.3%
2.09%
+14.8%
EOSE NewEOS ENERGY ENTERPRISES INC$1,6651,125,000
+100.0%
2.00%
OIH NewVANECK ETF TRUSToil services etf$1,5215,000
+100.0%
1.83%
ACGL NewARCH CAP GROUP LTDord$1,25620,000
+100.0%
1.51%
NewENOVIX CORPORATION$1,244100,000
+100.0%
1.50%
VEV NewVICINITY MOTOR CORP$1,0321,075,000
+100.0%
1.24%
NewALPHAVEST ACQUISITION CORPunit 06/19/2024$1,010100,000
+100.0%
1.22%
PLAY NewDAVE & BUSTERS ENTMT INC$88625,000
+100.0%
1.07%
ERF NewENERPLUS CORP$87950,000
+100.0%
1.06%
BuyMAIA BIOTECHNOLOGY INC$878
-99.9%
250,000
+25.1%
1.06%
+46.7%
ERJ NewEMBRAER S.A.sponsored ads$87580,000
+100.0%
1.05%
NewBRAGG GAMING GROUP INC$849219,900
+100.0%
1.02%
IPG NewINTERPUBLIC GROUP COS INC$66720,000
+100.0%
0.80%
BuyPHOENIX BIOTECH ACQUISITION$613
-99.8%
59,615
+50.5%
0.74%
+68.6%
VZ NewVERIZON COMMUNICATIONS INC$59115,000
+100.0%
0.71%
BuySIZZLE ACQUISITION CORP$512
-99.8%
50,001
+100.0%
0.62%
+124.0%
MNST NewMONSTER BEVERAGE CORP NEW$4574,500
+100.0%
0.55%
ELVT NewELEVATE CREDIT INC$405231,254
+100.0%
0.49%
CANO NewCANO HEALTH INC$343250,000
+100.0%
0.41%
NewVIZSLA SILVER CORP$285250,000
+100.0%
0.34%
EDSA NewEDESA BIOTECH INC$264121,845
+100.0%
0.32%
INFN NewINFINERA CORP$16925,000
+100.0%
0.20%
LTRN NewLANTERN PHARMA INC$7312,000
+100.0%
0.09%
NewIMMIX BIOPHARMA INC$5825,000
+100.0%
0.07%
ONCY NewONCOLYTICS BIOTECH INC$4125,000
+100.0%
0.05%
BuySPORTSMAP TECH ACQUISITIN CO*w exp 09/01/202$3
-99.9%
50,000
+17.9%
0.00%0.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-07
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BRIACELL THERAPEUTICS CORP8Q3 202326.0%
AMERICAS GOLD AND SILVER COR8Q3 20239.5%
INSPIRA TECHNOLOGIES OXY BHN8Q3 20231.7%
CINGULATE INC8Q3 20230.0%
CHAVANT CAPITAL ACQUISITN CO8Q3 20230.0%
PEARL HOLDINGS ACQUISITN COR7Q3 20233.6%
TARGET GLOBAL ACQUISI I CORP7Q3 20234.0%
TARGET GLOBAL ACQUISI I CORP7Q3 20232.1%
ROTH CH ACQUISITION V CO7Q3 20232.1%
PEARL HOLDINGS ACQUISITN COR7Q3 20231.9%

View Lynwood Capital Management Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Lynwood Capital Management Inc. Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
BriaCell Therapeutics Corp.February 14, 20231,460,0009.3%

View Lynwood Capital Management Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-10
13F-HR2024-02-14
13F-HR2023-11-01
13F-HR2023-08-14
13F-HR/A2023-05-15
13F-HR2023-05-12
SC 13G/A2023-02-14
13F-HR2023-02-07
13F-HR2022-10-25
13F-HR2022-08-02

View Lynwood Capital Management Inc.'s complete filings history.

Compare quarters

Export Lynwood Capital Management Inc.'s holdings